FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:697-699 August 30, 2001 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Seligsohn and Lubetsky (April 19 issue)¹ justify not routinely testing white women for inherited thrombophilia before prescribing oral contraceptives, since "it would deny contraceptives to about 5 to 10 percent of white women . . . while preventing very few fatal thromboembolisms." This is not acceptable. No woman should die unnecessarily from complications of contraceptive use, nor should any woman be subjected to a possible stroke, pulmonary embolism, or deep venous thrombosis when the occurrence of these complications could have possibly been prevented by a simple and accurate blood test. Other acceptable forms of birth control are . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.